November 30, 2016 - By Louis Casey
Equity research analysts at Goldman Sachs initiated coverage on STERIS Corporation (NYSE:STE) with “Neutral” rating. This was shared with investors and clients in a report on 30 November.
Out of 2 analysts covering Steris (NYSE:STE), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $84 is the highest target while $82 is the lowest. The $83 average target is 26.12% above today’s ($65.81) stock price. Steris has been the topic of 3 analyst reports since November 2, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating given on Friday, June 3 by Northcoast.
About 162,298 shares traded hands. STERIS plc Ordinary Shares (NYSE:STE) has declined 7.62% since April 27, 2016 and is downtrending. It has underperformed by 12.85% the S&P500.
Analysts await STERIS plc Ordinary Shares (NYSE:STE) to report earnings on February, 14. They expect $1.04 earnings per share, up 6.12% or $0.06 from last year’s $0.98 per share. STE’s profit will be $90.08 million for 15.82 P/E if the $1.04 EPS becomes a reality. After $0.89 actual earnings per share reported by STERIS plc Ordinary Shares for the previous quarter, Wall Street now forecasts 16.85% EPS growth.
Insitutional Activity: The institutional sentiment decreased to 0.45 in 2016 Q2. Its down 1.15, from 1.6 in 2016Q1. The ratio worsened, as 0 funds sold all STERIS plc Ordinary Shares shares owned while 5 reduced positions. 6 funds bought stakes while 2 increased positions. They now own 350,212 shares or 21.74% more from 287,671 shares in 2016Q1.
Gsa Cap Ptnrs Llp has 0.02% invested in the company for 6,482 shares. Ghp Invest Advsr has 0.41% invested in the company for 27,728 shares. Huntington Bankshares accumulated 0% or 1,598 shares. Penobscot Invest Mgmt has 2,940 shares for 0.07% of their US portfolio. Hanson And Doremus Mgmt has invested 0.05% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE). Bragg Financial Advisors has invested 0.21% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE). West Coast Lc has invested 2.07% of its portfolio in STERIS plc Ordinary Shares (NYSE:STE). Mackenzie Corp last reported 0% of its portfolio in the stock. Westpac Bk Corporation owns 2,733 shares or 0% of their US portfolio. Moreover, Lmr Prns Limited Liability Partnership has 0.92% invested in STERIS plc Ordinary Shares (NYSE:STE) for 86,749 shares. Moreover, Axiom Ltd De has 0.05% invested in STERIS plc Ordinary Shares (NYSE:STE) for 26,187 shares. Yorktown Management & Rech Commerce Inc holds 4,500 shares or 0.07% of its portfolio. 12Th Street Asset Mgmt Ltd Liability Corp last reported 25,760 shares in the company. Vantage Inv Ltd Company, a Pennsylvania-based fund reported 20 shares. Citigroup, a New York-based fund reported 6,913 shares.
According to Zacks Investment Research, “Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company’s operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.”
More recent STERIS plc Ordinary Shares (NYSE:STE) news were published by: Equitiesfocus.com which released: “STERIS Corporation (NYSE:STE) PEG Ratio At 1.68” on November 25, 2016. Also Equitiesfocus.com published the news titled: “STERIS Corporation (NYSE:STE) 200-Day MA At $70.05” on November 07, 2016. Equitiesfocus.com‘s news article titled: “STERIS Corporation (NYSE:STE) Short-Term Price Target At $85.83” with publication date: November 16, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey